Statement to an Insufficient Systematic Review on Viscum album L. Therapy

Evidence-based Complementary and Alternative Medicine : ECAM
Harald MatthesFriedemann Schad

Abstract

Up to 88% of oncological patients apply complementary therapies and up to 77% apply complementary mistletoe therapy in the context of integrative oncological approaches. An evidence-based consultation of oncological health professionals regarding complementary therapies used in Germany is missing. Therefore, a new S3-Guideline for Complementary Medicine in the Treatment of Oncological Patients is under development and is anticipated to be finalized in November 2020. It will be based on evidence-based publications and systematic reviews on complementary therapies in oncology. A recently published two-part systematic review on mistletoe treatment in oncology has been reevaluated. The latest published systematic two-part review on mistletoe has been systematically proofread and checked in compliance with the Cochrane Handbook for Systematic Reviews of Intervention and the AMSTAR 2 (A MeaSurement Tool to Assess Systematic Reviews) tool. The here discussed two-part review is incomplete, lacks sound accuracy including insufficient assessment of the risk of bias, and contains imprecise statements. In addition, it does not sufficiently comply with the Cochrane Handbook for Systematic Reviews of Intervention and the AMSTAR 2 tool. In vi...Continue Reading

References

Nov 15, 2000·Deutsche medizinische Wochenschrift·K MünstedtU Kullmer
Mar 22, 2002·The Lancet Oncology·H Kiene
Jan 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U R KleebergUNKNOWN EORTC Melanoma Group in cooperation with the German Cancer Society (DKG)
Jun 27, 2006·BMC Medical Research Methodology·Harald WalachWayne B Jonas
Oct 24, 2006·Forschende Komplementärmedizin = Research in Complementary Medicine·Ronald Grossarth-Maticek, Renatus Ziegler
Mar 3, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·P A FaschingM R Bani
Jun 29, 2007·Forschende Komplementärmedizin = Research in Complementary Medicine·Ronald Grossarth-Maticek, Renatus Ziegler
Jun 13, 2009·Journal of Experimental & Clinical Cancer Research : CR·Gunver S KienleHelmut Kiene
Dec 4, 2009·Frontiers of Radiation Therapy and Oncology·O MickeR Mucke
Aug 30, 2011·BMC Complementary and Alternative Medicine·Gunver S KienleHelmut Kiene
Sep 4, 2012·Explore : the Journal of Science and Healing·Thomas Ostermann, Arndt Büssing
Dec 12, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gil Bar-SelaNissim Haim
Jul 31, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W TrögerM Milićević
Mar 29, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Megan L SteeleFriedemann Schad
Apr 5, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Wilfried TrögerMiodrag Matijašević
May 8, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Alessandra LonghiStefano Ferrari
Aug 22, 2014·Deutsches Ärzteblatt International·Wilfried TrögerMiroslav Milićević
Apr 25, 2017·CA: a Cancer Journal for Clinicians·Heather GreenleeDebu Tripathy
Oct 24, 2017·Journal of the National Cancer Institute·Sean KhozinRichard Pazdur
Nov 16, 2017·Journal of the National Cancer Institute. Monographs·Claudia M WittJun J Mao
Mar 7, 2018·Complementary Medicine Research·Friedemann SchadHarald Matthes
Jun 12, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanLorenzo Cohen
Sep 17, 2018·Complementary Therapies in Medicine·Anja ThronickeFriedemann Schad
Sep 27, 2018·BMC Complementary and Alternative Medicine·Loisa DrozdoffDaniela Paepke
Jan 24, 2019·Journal of Cancer Research and Clinical Oncology·M FreudingJutta Huebner
Jan 24, 2019·Journal of Cancer Research and Clinical Oncology·M FreudingJutta Huebner
May 23, 2019·Journal of Cancer Research and Clinical Oncology·H MatthesF Schad
Jul 16, 2019·Journal of Cancer Research and Clinical Oncology·Jutta HuebnerJ Buentzel

❮ Previous
Next ❯

Citations

Jul 2, 2020·Cells·Ling MaDavid Vermijlen
Sep 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Evelyn PeñalozaRafael Garrett

❮ Previous
Next ❯

Software Mentioned

Cochrane
AMSTAR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
L F Haas
Forschende Komplementärmedizin = Research in Complementary Medicine
Jörg MelzerReinhard Saller
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
E Ernst
Deutsche medizinische Wochenschrift
Daniela Umbreit
© 2021 Meta ULC. All rights reserved